Concepedia

Author

Tiziana Magnani

Fondazione IRCCS Istituto Nazionale dei TumoriORCID

Also Known As

M. Tiziana, Magnani, Tiziana, T. Magnani, Tiziana Magnani

56

Publications

678

Citations

14

H-Index

25

Concepts

All Affiliations

Fondazione IRCCS Istituto Nazionale dei TumoriUniversity of MilanIRCCS Humanitas Research HospitalErasmus MCRoyal Marsden NHS Foundation Trust
TM

About

Tiziana Magnani is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in urology, oncology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

301

2

Public Health

2

2

101

3

Education

1

1

18

4

Counseling

1

1

18

5

Health Behavior

1

1

12

Tiziana Magnani

×

14

Publications

572

Citations

12

H-Index

YearCitations

Predictors of Health-related Quality of Life and Adjustment to Prostate Cancer During Active Surveillance

Lara Bellardita, T. Rancati, M.F. Alvisi,

European Urology

2013

89

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

Elizabeth Bancroft, Elizabeth Page, Mark N. Brook,

The Lancet Oncology

2021

89

Is the alpha–beta ratio of prostate cancer really low? A prospective, non-randomized trial comparing standard and hyperfractionated conformal radiation therapy

R. Valdagni, C. Italia, P. Montanaro,

Radiotherapy and Oncology

2005

80

The requirements of a specialist Prostate Cancer Unit: A discussion paper from the European School of Oncology

R. Valdagni, Peter Albers, Chris Bangma,

European Journal of Cancer

2010

52

The 6‐year attendance of a multidisciplinary prostate cancer clinic in Italy: incidence of management changes

Tiziana Magnani, R. Valdagni, Roberto Salvioni,

British Journal of Urology

2012

51

Feasibility and Clinical Roles of Different Substaging Systems at First and Second Transurethral Resection in Patients with T1 High-Grade Bladder Cancer

Renzo Colombo, Rodolfo Hurle, Marco Moschini,

European Urology Focus

2016

48

Usefulness of pT1 substaging in papillary urothelial bladder carcinoma

Carlo Patriarca, Rodolfo Hurle, Marco Moschini,

Diagnostic Pathology

2016

47

Eleven-year Management of Prostate Cancer Patients on Active Surveillance: What have We Learned?

C. Marenghi, M.F. Alvisi, F. Palorini,

Tumori Journal

2017

25

Evaluation of Mediators Associated with the Inflammatory Response in Prostate Cancer Patients Undergoing Radiotherapy

N. Bedini, A. Cicchetti, F. Palorini,

Disease Markers

2018

22

Patient’s choice of observational strategy for early-stage prostate cancer

Lara Bellardita, Guendalina Graffigna, S. Donegani,

Neuropsychological Trends

2012

18

Page 1